Abstract | BACKGROUND AND OBJECTIVE: METHODS: The clinical data of 65 newly diagnosed elderly patients with AML were retrospectively analyzed. Among them, 45 patients received induction chemotherapy including standard cytarabine regimen (n = 21) and low dose cytarabine regimen (n = 24), and 20 patients received palliative treatment. The efficacy and prognosis were compared between the groups. RESULTS: There were no statistical differences in complete remission, overall survival and the 6-month disease-free survival rates between standard cytarabine group and low dose cytarabine group (P = 0.675, P = 0.775, P = 0.751, respectively). Significant difference in median overall survival and overall survival rate were detected (P < 0.001, P = 0.031, respectively), but no significant difference in early death rate (P = 0.238) was found between induction chemotherapy group and palliative treatment group. Multivariate analysis showed that the white blood cells count ≥ 100.0 × 109/L was associated with early death. CONCLUSIONS:
|
Authors | Jianping Mao, Wenliang Gao, Lianguo Xue, Lidong Zhao, Lei Miao, Tao Jia, Yuanxin Zhu, Ying Wang, Lijuan Meng, Juan Wang |
Journal | American journal of blood research
(Am J Blood Res)
Vol. 10
Issue 6
Pg. 320-329
( 2020)
ISSN: 2160-1992 [Print] United States |
PMID | 33489440
(Publication Type: Journal Article)
|
Copyright | AJBR Copyright © 2020. |